Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
April 18, 2024

Biocon signs licensing and supply deal for diabetes drug in Brazil

Biocon, an India-based biopharmaceutical company, has entered into an exclusive licensing and supply agreement with Brazilian specialty pharmaceutical company Biomm for the commercialisation of Semaglutide (gOzempic), a drug used to improve glycemic control in adults with type-2 diabetes.

Continue
Brazil is claimed to be the fifth country in the world with the highest incidence of diabetes. Credit: Tesa Robbins from Pixabay.
April 17, 2024

Orladeyo gains approval in Brazil for HAE prevention

Brazil's Health Regulatory Agency (ANVISA) approves Orladeyo. Credit: Mustafa shehadeh from Pixabay.
April 16, 2024

Telix Pharmaceuticals secures FDA fast track status for TLX101-CDx

The company is preparing its US NDA for TLX101-CDx for both adult and paediatric patients. Credit: Michal Jarmoluk from Pixabay.

Contracts

December 14, 2022

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Micrograph of psoriasis vulgaris. Credit: Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann,Errol P. Prens and Jeffrey Damman/ commons.wikimedia.org.

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Kite, Refuge sign license deal for gene expression platform for blood cancers

Deals

Deals March 26, 2024

Q32 Bio concludes merger deal with Homology Medicines

Pharmaceutical Business Review

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Kindeva Drug Delivery acquires Summit Biosciences

Alfasigma to acquire Galapagos’ Jyseleca business

Popular

  1. Immuno-oncology company Portage Biotech to evaluate strategic alternatives
  2. NICE recommends Novartis’ CAR-T therapy for leukaemia
  3. TORL BioTherapeutics secures $158m for oncology pipeline development
  4. Invenra, Astellas sign bispecific antibody discovery agreement
  5. FDA approves ViiV Healthcare’s Dovato for adolescent HIV treatment

PRESS RELEASES

Gerresheimer Performance Levels Simplify Choice of Optimum Solution
Gerresheimer Performance Levels Simplify Choice of Optimum Solution
Sofgen Pharmaceuticals to Exhibit at CPhI North America 2024
Sofgen Pharmaceuticals to Exhibit at CPhI North America 2024
Molnar Institute at Analytica 2024 – 9-12 April in Munich, Germany
Molnar Institute at Analytica 2024 – 9-12 April in Munich, Germany
Gerresheimer Decisively Continues on Profitable Growth Course in Financial Year 2023
Gerresheimer Decisively Continues on Profitable Growth Course in Financial Year 2023
Butterworth at Making Pharmaceuticals 2024 – 23-24 April in Coventry, UK
Butterworth at Making Pharmaceuticals 2024 – 23-24 April in Coventry, UK

Suppliers

Whitepapers

Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation
Topicals – Selecting the Right Antiseptic for Your Formulation
Topicals – Selecting the Right Antiseptic for Your Formulation
Oral Formulations – Selecting the Right Antiseptic for Your Formulation
Oral Formulations – Selecting the Right Antiseptic for Your Formulation